MariMed Inc. (MRMD) Reports 69% Jump in Q1 2019 Revenues, Adopts Growth Strategy
MRMD improved its adjusted EBITDA in Q1 2019 by 76 percent The company’s multipronged strategy for growth includes continued consolidation of cannabis operations and the launch of a subsidiary MariMed CEO identified the company as a “significant early mover” in the burgeoning CBD health and wellness market MariMed Inc. (OTCQB: MRMD) recorded a 69 percent jump in revenues to $3,515,815 for the three months ended March 31, 2019, as compared to $2,082,950 for the comparable period of the prior year. The company’s gross profit for the quarter rose 90 percent, to $2,261,025, from $1,194,081 for the same period in 2018.…
